Hervé Watier

767 total citations
10 papers, 594 citations indexed

About

Hervé Watier is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Nephrology. According to data from OpenAlex, Hervé Watier has authored 10 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Nephrology. Recurrent topics in Hervé Watier's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Hervé Watier is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Hervé Watier collaborates with scholars based in France, Australia and Morocco. Hervé Watier's co-authors include David Ternant, Gilles Paintaud, Danielle Degenne, Charlotte Magdelaine–Beuzelin, Alexandre Aubourg, Laurence Picon, Marc Ohresser, Valérie Gouilleux‐Gruart, Thierry Lecomte and P. Bardos and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Hervé Watier

10 papers receiving 580 citations

Peers

Countries citing papers authored by Hervé Watier

Since Specialization

Citations

This map shows the geographic impact of Hervé Watier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Watier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Watier more than expected).

Fields of papers citing papers by Hervé Watier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Watier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Watier. The network helps show where Hervé Watier may publish in the future.

Co-authorship network of co-authors of Hervé Watier

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Watier. A scholar is included among the top collaborators of Hervé Watier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Watier. Hervé Watier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis 2020 ·Frontiers in Immunology ·(unknown), Roxane Lemoine, Eric Morello, (unknown), (unknown), (unknown), Astrid Musnier, Anne Poupon, Martine Pugnière, (unknown), D. Nouar, Valérie Gouilleux‐Gruart, Hervé Watier, Brice Korkmaz, C. Hoarau	8
2	Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule 2015 ·mAbs ·Philippe Gatault, Guillaume Brachet, David Ternant, Danielle Degenne, (unknown), Christelle Barbet, Emmanuel Gyan, Valérie Gouilleux‐Gruart, (unknown), (unknown), Jean‐Michel Halimi, Hervé Watier	61
3	Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients 2011 ·Clinical Cancer Research ·Nicolas Azzopardi, Thierry Lecomte, David Ternant, Michelle Boisdron-Celle, Friedrich Piller, Alain Morel, Valérie Gouilleux‐Gruart, (unknown), Hervé Watier, Érick Gamelin, Gilles Paintaud	80
4	An Enzyme-Linked Immunosorbent Assay to Study Bevacizumab Pharmacokinetics 2010 ·Therapeutic Drug Monitoring ·David Ternant, (unknown), Thierry Lecomte, Danielle Degenne, (unknown), Hervé Watier, Étienne Dorval, Gilles Paintaud	32
5	Rituximab efficiency in children with steroid-dependent nephrotic syndrome 2010 ·Pediatric Nephrology ·Anne‐Laure Sellier‐Leclerc, Marie‐Alice Macher, Chantal Loirat, Valérie Guérin, Hervé Watier, Michel Peuchmaur, Véronique Baudouin, Georges Deschênes	68
6	Therapeutic antibodies in ophthalmology 2010 ·mAbs ·Charlotte Magdelaine–Beuzelin, (unknown), Gilles Paintaud, Hervé Watier	20
7	VEGF Polymorphisms are Associated With an Increasing Risk of Developing Renal Cell Carcinoma 2010 ·The Journal of Urology ·F. Bruyère, Christopher M. Hovens, (unknown), B. Faivre d’Arcier, Anthony J. Costello, Hervé Watier, Claude Linassier, Marc Ohresser	40
8	Infliximab Pharmacokinetics in Inflammatory Bowel Disease Patients 2008 ·Therapeutic Drug Monitoring ·David Ternant, Alexandre Aubourg, Charlotte Magdelaine–Beuzelin, Danielle Degenne, Hervé Watier, Laurence Picon, Gilles Paintaud	151
9	Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20 2008 ·Blood ·(unknown), David Ternant, Marc Ohresser, Stéphanie Lerondel, Sabrina Pesnel, Hervé Watier, Alain Le Pape, P. Bardos, Gilles Paintaud, Guillaume Cartron	91
10	FcγRIIIa Expression Is Not Increased on Natural Killer Cells Expressing the FcγRIIIa-158V Allotype 2008 ·Cancer Research ·Nicolas Congy‐Jolivet, (unknown), David Ternant, Marc Ohresser, Hervé Watier, Gilles Thibault	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact